FDA Clearance for Redsense Safety Device for Home use During Home Hemodialysis
Author: Redsense Medical AB
Synopsis and Key Points:
Redsense Medical Receives FDA Clearance for the Redsense Safety Device for Home/Self use During Home Hemodialysis.
Main DigestRedsense Medical Receives FDA Clearance for the Redsense Safety Device for Home/Self use During Home Hemodialysis.
The Redsense safety device is now cleared by FDA for Home/Self use and is consequently available to all patients with home hemodialysis in the US. Redsense safety device is designed to detect venous needle dislodgement during hemodialysis and its use has already improved in-clinic patient safety. Optimizing safety conditions for home hemodialysis users is a core ambition for Redsense Medical.
Dialysis equipment today is required to have a system which protects the patient from blood loss due to dislodgement of the venous needle. The commonly accepted solution is to monitor by the venous pressure alarm but a better solution has long been requested. Even with the routine supervision of medical staff still the venous needle can become dislodged: the dialysis machine will then continue to draw blood from the patient's artery however not returning blood in the loop circuit as the venous needle has become dislodged and the patient's blood ends up elsewhere. If undetected, this blood loss can have very serious consequences in only a few minutes. Redsense safety device provides a solution to this problem and detects venous needle dislodgement instantaneously; it only takes a few milliliters of blood on the sensor patch to sound the alarm.
It is well known that home hemodialysis allows for daily treatments, improving quality of life, morbidity and life expectancy. Home hemodialysis is also more cost-effective as it can free hospital beds and reduces the transport costs related to centralized dialysis care.
Being able to address the market for home hemodialysis is an important step according to, CEO Patrik Byhmer:
"This is where Redsense really can make a difference. It's very satisfying being able to increase the level of safety among the users of home hemodialysis."
Redsense Medical has offices in Sweden and in the U.S. (Chicago, IL). For more information: www.redsensemedical.com.
The Redsense safety device is the results of close co-operation between medical staff and engineers. Redsense consists of two parts: a sensor patch and an alarm unit. An infrared signal is transmitted from the alarm unit to the sensor patch using fiber optic cable. In the event of bleeding, inner layers of the patch smear blood over the optical sensor, which triggers the alarm.
- 1 - Safety and Effectiveness of Consumer Hand Sanitizers : U.S. Food and Drug Administration (2019/04/11)
- 2 - Scammers Target Consumers with Fake FDA Warning Letters : U.S. Food and Drug Administration (2018/07/13)
- 3 - Automated Insulin Delivery and Monitoring System for Younger Pediatric Patients Approved by FDA : U.S. Food and Drug Administration (FDA) (2018/06/21)
- 4 - FDA Approves Glucose Monitoring System with Sensor and App for Adults with Diabetes : U.S. Food and Drug Administration (FDA) (2018/06/21)
- 5 - Toxoplasmosis Parasite Infection Test : U.S. Food and Drug Administration (2011/05/24)
- 6 - Generic Version of EpiPen Approved by U.S. FDA : U.S. Food and Drug Administration (2018/08/19)
- 7 - US FDA Authorizes First Fully Interoperable Continuous Glucose Monitoring System : U.S. Food and Drug Administration (2018/03/29)
• Disabled World is strictly a news and information website provided for general informational purpose only and does not constitute medical advice. Materials presented are in no way meant to be a substitute for professional medical care by a qualified practitioner, nor should they be construed as such. Any 3rd party offering or advertising on disabled-world.com does not constitute endorsement by Disabled World.
• Please report outdated or inaccurate information to us.